265 related articles for article (PubMed ID: 32706396)
1. Coagulation dysfunction is associated with severity of COVID-19: A meta-analysis.
Zhu J; Pang J; Ji P; Zhong Z; Li H; Li B; Zhang J; Lu J
J Med Virol; 2021 Feb; 93(2):962-972. PubMed ID: 32706396
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 and coagulation dysfunction in adults: A systematic review and meta-analysis.
Lin J; Yan H; Chen H; He C; Lin C; He H; Zhang S; Shi S; Lin K
J Med Virol; 2021 Feb; 93(2):934-944. PubMed ID: 32706426
[TBL] [Abstract][Full Text] [Related]
3. Risk factors of severe cases with COVID-19: a meta-analysis.
Ou M; Zhu J; Ji P; Li H; Zhong Z; Li B; Pang J; Zhang J; Zheng X
Epidemiol Infect; 2020 Aug; 148():e175. PubMed ID: 32782035
[TBL] [Abstract][Full Text] [Related]
4. The effect of coagulation factors in 2019 novel coronavirus patients: A systematic review and meta-analysis.
Xiang G; Hao S; Fu C; Hu W; Xie L; Wu Q; Li S; Liu X
Medicine (Baltimore); 2021 Feb; 100(7):e24537. PubMed ID: 33607784
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of coagulation parameters associated with disease severity and poor prognosis of COVID-19.
Zhang A; Leng Y; Zhang Y; Wu K; Ji Y; Lei S; Xia Z
Int J Infect Dis; 2020 Nov; 100():441-448. PubMed ID: 32947052
[TBL] [Abstract][Full Text] [Related]
6. Severe COVID-19 and coagulopathy: A systematic review and meta-analysis.
Mitra S; Ling RR; Yang IX; Poon WH; Tan CS; Monagle P; MacLaren G; Ramanathan K
Ann Acad Med Singap; 2021 Apr; 50(4):325-335. PubMed ID: 33990820
[TBL] [Abstract][Full Text] [Related]
7. Coagulopathy in patients with COVID-19: a systematic review and meta-analysis.
Zhang X; Yang X; Jiao H; Liu X
Aging (Albany NY); 2020 Nov; 12(24):24535-24551. PubMed ID: 33229625
[TBL] [Abstract][Full Text] [Related]
8. Anaemia and enhancement of coagulation are associated with severe COVID-19 infection.
Helin TA; Lemponen M; Lahtiharju T; Koskinen M; Lassila R; Joutsi-Korhonen L
Scand J Clin Lab Invest; 2021 Dec; 81(8):653-660. PubMed ID: 34793272
[TBL] [Abstract][Full Text] [Related]
9. Venous thromboembolic events in patients with COVID-19: a systematic review and meta-analysis.
Wu T; Zuo Z; Yang D; Luo X; Jiang L; Xia Z; Xiao X; Liu J; Ye M; Deng M
Age Ageing; 2021 Feb; 50(2):284-293. PubMed ID: 33201226
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of relevant indicators of coagulation and fibrinolysis in patients with varying severity of community-acquired pneumonia].
Xu Y; Zhang Y; Jiang F; Zheng H; Zhang Y; Pang G; Yang L; Zhang Q
Zhonghua Yi Xue Za Zhi; 2015 Jun; 95(24):1925-9. PubMed ID: 26710695
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of cardiac biomarkers in COVID-19 infection.
Sheth A; Modi M; Dawson D; Dominic P
Sci Rep; 2021 Mar; 11(1):4930. PubMed ID: 33654230
[TBL] [Abstract][Full Text] [Related]
12. Elevated D-dimer levels on admission are associated with severity and increased risk of mortality in COVID-19: A systematic review and meta-analysis.
Gungor B; Atici A; Baycan OF; Alici G; Ozturk F; Tugrul S; Asoglu R; Cevik E; Sahin I; Barman HA
Am J Emerg Med; 2021 Jan; 39():173-179. PubMed ID: 33069541
[TBL] [Abstract][Full Text] [Related]
13. Association of coagulation disturbances with severity of COVID-19: a longitudinal study.
Lu H; Chen M; Tang S; Yu W
Hematology; 2021 Dec; 26(1):656-662. PubMed ID: 34493174
[TBL] [Abstract][Full Text] [Related]
14. Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count.
Bi X; Su Z; Yan H; Du J; Wang J; Chen L; Peng M; Chen S; Shen B; Li J
Platelets; 2020 Jul; 31(5):674-679. PubMed ID: 32367765
[TBL] [Abstract][Full Text] [Related]
15. D-Dimer and Prothrombin Time Are the Significant Indicators of Severe COVID-19 and Poor Prognosis.
Long H; Nie L; Xiang X; Li H; Zhang X; Fu X; Ren H; Liu W; Wang Q; Wu Q
Biomed Res Int; 2020; 2020():6159720. PubMed ID: 32596339
[TBL] [Abstract][Full Text] [Related]
16. Impact of initial coagulation and fibrinolytic markers on mortality in patients with severe blunt trauma: a multicentre retrospective observational study.
Ishii K; Kinoshita T; Kiridume K; Watanabe A; Yamakawa K; Nakao S; Fujimi S; Matsuoka T
Scand J Trauma Resusc Emerg Med; 2019 Feb; 27(1):25. PubMed ID: 30819212
[TBL] [Abstract][Full Text] [Related]
17. The most important biomarker associated with coagulation and inflammation among COVID-19 patients.
Hong LZ; Shou ZX; Zheng DM; Jin X
Mol Cell Biochem; 2021 Jul; 476(7):2877-2885. PubMed ID: 33742367
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of the factors associated with abnormal coagulation and prognosis
in patients with non-small cell lung cancer].
Li Y; Wei S; Wang J; Hong L; Cui L; Wang C
Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):789-96. PubMed ID: 25404269
[TBL] [Abstract][Full Text] [Related]
19. Can we predict the severity of coronavirus disease 2019 with a routine blood test?
Zeng F; Li L; Zeng J; Deng Y; Huang H; Chen B; Deng G
Pol Arch Intern Med; 2020 May; 130(5):400-406. PubMed ID: 32356642
[TBL] [Abstract][Full Text] [Related]
20. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis.
Henry BM; de Oliveira MHS; Benoit S; Plebani M; Lippi G
Clin Chem Lab Med; 2020 Jun; 58(7):1021-1028. PubMed ID: 32286245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
